BioNexus Gene Lab Corp Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.21M0.13M11.39M13.36M10.93M9.77M9.51M
Cost of Revenue 0.18M0.07M9.67M11.10M9.67M8.44M8.22M
Gross Profit 0.03M0.06M1.72M2.27M1.26M1.33M1.29M
Operating items
Research & Development 0.05M0.05M
Selling, General & Administrative -0.24M0.36M1.33M1.28M1.73M2.44M1.97M
Restructuring Costs 1.33M1.28M1.73M2.44M1.97M
Other Operating Expenses -1.33M-9.35M-8.93M
Operating Expenses -0.24M0.36M1.33M2.56M3.46M-4.41M-4.94M
Operating Income 0.06M-0.28M1.27M1.06M-0.29M-2.59M-1.57M
EBIT 0.06M-0.28M1.27M1.06M-0.29M-2.59M-1.57M
Non-operating items
Interest & Investment Income 0.07M0.15M
Other Non Operating Income -0.03M0.01M0.15M-0.23M0.49M2.07M
Non Operating Income -0.03M0.03M0.49M2.07M
Net income details
EBT 0.06M-0.28M1.26M1.04M-0.30M-2.61M-1.59M
Tax Provisions -0.03M0.02M0.17M-0.29M-0.05M-0.02M-0.00M
Profit After Tax 0.03M-0.25M1.09M0.75M-0.36M-2.63M-1.60M
Equity Income 0.31M0.07M
Income from Continuing Operations 0.09M-0.30M1.09M1.33M-0.25M-2.59M-1.59M
Consolidated Net Income 0.09M-0.30M1.09M1.33M-0.25M-2.59M-1.59M
Income towards Parent Company 0.09M-0.30M1.09M1.33M-0.25M-2.59M-1.59M
Net Income towards Common Stockholders 0.09M-0.30M1.09M1.33M-0.25M-2.63M-1.60M
Additional items
EPS (Basic) 0.15-0.330.010.94-0.17-1.49-0.89
EPS (Weighted Average and Diluted) -0.17-0.09
Shares Outstanding (Weighted Average) 0.62M0.91M0.86M1.43M1.45M1.77M1.80M
Shares Outstanding (Diluted Average) 15.88M17.82M
EBITDA -0.01M-0.24M1.24M0.52M-0.66M-2.90M-1.48M
Interest Expenses -0.01M-0.01M-0.01M0.01M0.02M
Tax Rate 13.44%17.23%0.83%0.22%